Literature DB >> 2823155

Effect of clofibrate on brain mevalonate-5-pyrophosphate decarboxylase.

M F Zafra1, S Riquelme, M Castillo, E Garcia-Peregrin.   

Abstract

The effect of clofibrate on the activity of the three mevalonate-activating enzymes has been studied for the first time in brain by reactions carried out using [2-14C] mevalonic acid as substrate and 105,000 g supernatants from 14-day-old chick brain. Mevalonate-5-pyrophosphate decarboxylase was clearly inhibited, while mevalonate kinase and mevalonate-5-phosphate kinase were not significantly affected. The effect of clofibrate on decarboxylase activity was progressive with increasing concentrations (1.25-5.00 mM) of the inhibitor. A transient inhibition and a subsequent activation as a function of clofibrate concentration seemed to occur for mevalonate kinase. Direct measurements of decarboxylase activity utilizing [2-14C] pyrophosphomevalonate as the specific substrate of this enzyme corroborated these results. Kinetic studies showed that clofibrate competes with the substrate ATP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823155     DOI: 10.1007/BF00971516

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

1.  Decarboxylation of mevalonate pyrophosphate is one rate-limiting step in hepatic cholesterol synthesis in suckling and weaned rats.

Authors:  C K Ramachandran; S N Shah
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.

Authors: 
Journal:  Br Heart J       Date:  1978-10

3.  Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats.

Authors:  M N Cayen; W T Robinson; J Dubuc; D Dvornik
Journal:  Biochem Pharmacol       Date:  1979-04-01       Impact factor: 5.858

4.  Inhibition of sterol synthesis in vitro by metabolites of phenylalanine.

Authors:  S N Shah; N A Peterson; C M McKean
Journal:  Biochim Biophys Acta       Date:  1969

5.  Relationship between changes in free cholesterol and pyrophosphomevalonate decarboxylase activity during myelination.

Authors:  C Marco; D Gonzalez-Pacanowska; A Linares; E Garcia-Peregrin
Journal:  Neurochem Res       Date:  1983-06       Impact factor: 3.996

6.  The effect of diabetes, nutritional factors, and sex on rat liver and kidney mevalonate kinase, mevalonate-5-phosphate kinase, and mevalonate-5-pyrophosphate decarboxylase.

Authors:  A M Jabalquinto; E Cardemil
Journal:  Arch Biochem Biophys       Date:  1981-08       Impact factor: 4.013

7.  Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.

Authors:  C Shama Bhat; T Ramasarma
Journal:  Biochem J       Date:  1979-07-01       Impact factor: 3.857

8.  Secondary regulatory sites in rat liver cholesterol biosynthesis: role of 5-pyrophosphomevalonate decarboxylase.

Authors:  A M Jabalquinto; E Cardemil
Journal:  Lipids       Date:  1980-03       Impact factor: 1.880

9.  Effect of alpha-p-chlorophenoxyisobutyrate on the metabolism of isoprenoid compounds in the rat.

Authors:  K V Krishnaiah; T Ramasarma
Journal:  Biochem J       Date:  1970-02       Impact factor: 3.857

10.  Brain phosphorylation and decarboxylation of mevalonic acid in the neonatal chick.

Authors:  D Gonzalez-Pacanowska; J García-Martinez; E García-Peregrín
Journal:  Enzyme       Date:  1981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.